Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Co-Diagnostics, Inc. (CODX) had Cost of Goods Sold of $0.19M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.15M |
|
$-9.14M |
|
|
Cost of Goods Sold |
$0.19M |
$-0.05M |
|
$9.35M |
|
$-9.21M |
|
$0.07M |
|
$-9.14M |
|
$-9.21M |
|
$-9.14M |
|
$-9.14M |
|
$-9.14M |
|
$-9.22M |
|
$-9.21M |
|
$-8.95M |
|
2.25M |
|
2.25M |
|
$-4.06 |
|
$-4.06 |
|
| Balance Sheet Financials | |
$9.78M |
|
$2.16M |
|
$11.72M |
|
$21.50M |
|
$4.28M |
|
-- |
|
$1.17M |
|
$5.46M |
|
$16.04M |
|
$8.82M |
|
$16.04M |
|
3.60M |
|
| Cash Flow Statement Financials | |
$-7.85M |
|
$-0.14M |
|
$4.33M |
|
$11.88M |
|
$8.23M |
|
$-3.65M |
|
$0.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.28 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-32.76% |
|
-6309.12% |
|
-6309.12% |
|
-- |
|
-6261.92% |
|
-6262.27% |
|
$-7.99M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.23 |
|
1.77 |
|
50.80 |
|
-56.97% |
|
-103.59% |
|
-42.51% |
|
-56.97% |
|
$4.45 |
|
$-3.54 |
|
$-3.48 |
|